HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Regions

Southeast Asia

Nine countries, 3,937 observations from 11 sources, covering 2000 to 2026. Four national programmes are read directly; the remainder appear through the international aggregators. Each country page states which sources stand behind its figures.

External HIV financing to Southeast Asia, by source of funds
OECD CRS · purpose code 13040
$0$100m$200m$300m20022005200820112014201720202023$212.6m$67.5m$140.6m
  • All donors
  • United States
  • The Global Fund
YearAll donorsUnited StatesThe Global Fund
2002 $34.5m
2003 $83.4m $46.5m
2004 $123.8m $53.4m
2005 $161.7m $55.7m $41.8m
2006 $186.5m $56.3m
2007 $220.2m $69.2m
2008 $227.6m $88.1m $83.3m
2009 $255.7m $97.8m $85.8m
2010 $254.3m $100.5m $99.8m
2011 $333.9m $103.0m $164.7m
2012 $250.2m $92.9m $101.2m
2013 $305.8m $79.7m $178.7m
2014 $233.8m $72.5m $125.8m
2015 $163.2m $54.3m $78.3m
2016 $195.0m $61.7m $118.6m
2017 $252.4m $66.4m $173.6m
2018 $145.1m $67.8m $67.3m
2019 $138.3m $42.1m $89.5m
2020 $303.2m $68.9m $154.4m
2021 $243.0m $60.4m $171.9m
2022 $202.4m $57.6m $138.5m
2023 $286.3m $71.6m $204.3m
2024 $212.6m $67.5m $140.6m

23 rows, as drawn above. Values are rounded for reading; the download carries them unrounded.

Disbursements reported to the OECD by all donors, by the United States alone, and by the Global Fund, summed across the nine countries. A year is drawn only when at least seven of the nine countries reported for that year, because a total built from four or five countries is low for a reason that has nothing to do with how much money was disbursed. For all donors combined, all nine countries reported in every year. For the United States, fewer than seven countries reported in 2002. For the Global Fund, fewer than seven countries reported in 2003, 2004, 2006 and 2007, so its line is broken between 2005 and 2008 and 2005 is drawn as a single point.

The same United States flow, recorded twice
OECD CRS · ForeignAssistance.gov
$0$50m$100m20032006200920122015201820212024$67.5m$11.9m
  • OECD reporting
  • United States self-reporting
YearOECD reportingUnited States self-reporting
2003 $46.5m $39.5m
2004 $53.4m $31.9m
2005 $55.7m $51.5m
2006 $56.3m $58.3m
2007 $69.2m $62.6m
2008 $88.1m $74.3m
2009 $97.8m $98.5m
2010 $100.5m $98.3m
2011 $103.0m $88.3m
2012 $92.9m $94.2m
2013 $79.7m $84.2m
2014 $72.5m $77.0m
2015 $54.3m $51.6m
2016 $61.7m $59.1m
2017 $66.4m $62.0m
2018 $67.8m $54.3m
2019 $42.1m $46.7m
2020 $68.9m $55.5m
2021 $60.4m $15.8m
2022 $57.6m $61.2m
2023 $71.6m $61.2m
2024 $67.5m $56.3m
2025 $36.8m
2026 $11.9m°

24 rows, as drawn above. A value marked ° comes from a reporting period that is still open or that the source marks as incomplete. Values are rounded for reading; the download carries them unrounded.

These two records are the panel's one independent pair on funding: (1) what the United States reports to the OECD, and (2) what it publishes itself. Where they diverge, the divergence carries meaningful information instead of being an artefact of republication. The self-reported series runs later because it is filed on a fiscal year. The point at 2026 is drawn from a reporting period that is still open or that the source marks as incomplete, and is shown as an open ring. Do not read it as a fall.

The epidemic and the treatment response
UNAIDS AIDSinfo
01m2m2000200320062009201220152018202120242,103,0001,373,200
  • People living with HIV
  • People on antiretroviral treatment
YearPeople living with HIVPeople on antiretroviral treatment
2000 1,355,000
2001 1,411,030
2002 1,441,200
2003 1,484,530
2004 1,518,060
2005 1,541,700
2006 1,595,930
2007 1,641,670
2008 1,667,600
2009 1,694,440
2010 1,742,280 379,800
2011 1,769,930 431,700
2012 1,807,980 488,900
2013 1,837,000 558,100
2014 1,866,100 625,600
2015 1,897,200 718,400
2016 1,909,200 822,100
2017 1,934,300 888,100
2018 1,959,400 981,000
2019 1,978,500 1,055,820
2020 1,997,600 1,115,830
2021 2,019,700 1,165,670
2022 2,061,800 1,211,000
2023 2,072,900 1,275,100
2024 2,103,000 1,373,200

25 rows, as drawn above. Values are rounded for reading; the download carries them unrounded.

Modelled estimates for the nine countries combined. The gap between the two lines is the treatment gap, and it is the quantity most exposed to a change in external financing.

Countries

9 in scope

Bilateral agreements

America First Global Health Strategy

The United States is replacing its previous assistance arrangements with country-by-country agreements. Only two have been signed with countries in this region so far, out of 34 worldwide. Terms are recorded as published; where a figure was not stated, the cell is left empty.

CountrySignedTotalUS share Country co-investmentProgramme areasCovers HIV
Cambodia 2026-04-02 $36.1m $30.8m $5.3m HIV/AIDS; TB; Malaria; GHS Yes
Philippines 2026-04-07 not stated not stated not stated HIV/AIDS; TB; GHS Yes

Source: KFF tracker of America First bilateral global health agreements, read 20 July 2026.

What this region page does not yet show

There is no sub-national breakdown outside the Philippines, and no service-level reporting outside Cambodia, Indonesia and Thailand. Vietnam's national programme dashboard is offline; Malaysia, Myanmar, Laos and Timor-Leste appear through the aggregators only. The country-by-country position is set out in Methods.